CARIS builds on its current genomics module integration within the nation’s largest provider of electronic medical records to offer access to and translation of Caris results from molecular profiles directly into patient records via Epic’s Order and Results Anywhere (ORA) network .
IRVING, Texas, July 7, 2022 /PRNewswire/ — Caris Life Sciences® (Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, today announced an expanded partnership with Epic, a Pioneer, Announced. Electronic Health Record (EHR) software system to integrate Carris’ market-leading molecular testing portfolio with Epic’s Orders and Results Anywhere (ORA) network.
“Caris Life Sciences is committed to delivering on our organizational promise to bring personalized precision medicine to as many physicians and patients as possible,” said David Spetzler, MS, PhD, MBA, President and Chief Scientific Officer of Caris. “Building on the success of our Epic Genomics Module integration, ORA will continue to improve patient access to the critical molecular outcomes they need to fight and hopefully beat cancer.”
ORA network integration, available later this year, is an important next step to fully enable data-driven decision making for Epic Systems users, who represent 60% of oncologists in the US, to test order. By integrating and direct output into Epic ORA, CARIS can streamline clinical workflow for clinicians and provide access to genomic data structured in their Epic environment.
“Integrations like ours with Caris Life Sciences directly benefit patients by improving access to study results and the efficiencies that make informed treatment decisions,” said Alan Hutchison, vice president of population health at Epic. “We are excited about this increased partnership with CARIS to further improve access to health and care and provide the opportunity to bring precision medicine to as many communities as possible.”
CARIS’ full suite of molecular profiling services, including whole exome and whole transcriptome sequencing for tissue and blood samples, will be available within the ORA network. CARIS is the first partner with full exome and full transcriptome sequencing capabilities to join Epic’s ORA network and plans to continue working with EHR Systems to explore new ways to integrate genomic results into patient care and education .
About Caris Life Sciences
Caris Life Sciences® (Caris) is a leading molecular science and technology company that actively creates and delivers innovative solutions to revolutionize healthcare and improve patient outcomes. By applying extensive molecular profiling (whole exome and whole transcriptome sequencing) and advanced artificial intelligence (AI) and machine learning algorithms, CARIS has built large-scale clinical genomic databases and cognitive computing that analyze and analyze molecular complexity. required to find out. Illness. This information provides an unmatched resource and an ideal avenue for conducting fundamental research to accelerate the quest for detection, diagnosis, monitoring, therapy selection, and drug development to improve the human condition.
With a primary focus on cancer, the CARIS suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to uncover a molecular blueprint that enables patients, clinicians and researchers to better locate, diagnose and treat patients. helps to heal them. The latest advancement from CARIS is a blood-based circulating nucleic acid sequencing (CNAS) assay that combines comprehensive molecular analysis (whole exome and whole transcriptome sequencing from blood) and serial monitoring, making it the most powerful liquid biopsy assay ever developed. Is.
Caris is headquartered in Irving, Texas with offices in Phoenix, New York, Denver, Tokyo, Japan and Basel, Switzerland. Caris provides services throughout the Americas, Europe, Asia and other international markets. To learn more, please visit CarisLifeSciences.com or follow us on Twitter (@CarisLS,
To learn more about Epic, please visit www.epic.com/about.
Caris Life Sciences media contact:
Epic media contact:
Source Caris Life Sciences